Abstract Details

Title Evaluation of neurofilament heavy chain as a marker of neuroaxonal pathology and prognosis in acute encephalitis

Topic Global Health and Neuroepidemiology

Presentation(s) (-)

Poster/Presentation
Number 006

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Johann Sellner, MD, FAAN (Neurologie, LK Mistelbach) PRESENTER	Dr. Sellner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Boehringer, Celgene, Immunic, Merck, Novartis, Roche, Sanofi. Dr. Sellner has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion, Biogen, Immunic, Merck, Novartis, Roche, Sanofi. Dr. Sellner has received personal compensation in the range of $0-$499 for serving as a Reviewer with Ethics Committtee.
Nicholas Davies	No disclosure on file
	No disclosure on file
	No disclosure on file
Vikas Kotagal, MD, FAAN (University of Michigan)	Dr. Kotagal has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders Society. The institution of Dr. Kotagal has received research support from NIH. The institution of Dr. Kotagal has received research support from VA Healthcare System.

��ɫ����